日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and validation of the utLIFE-PC algorithm for noninvasive detection of prostate cancer in urine: A prospective, observational study

utLIFE-PC 算法的开发和验证,用于尿液中前列腺癌的无创检测:一项前瞻性观察性研究

Sujun Han, Mingshuai Wang, Yong Wang, Junlong Wu, Zhaoxia Guo, Huina Wang, Ranlu Liu, Xiaofu Qiu, Linjun Hu, Jianbin Bi, Weigang Yan, Hengqing An, Gejun Zhang, Yi Zhi, Zhiyuan Chen, Libin Chen, Lei Liu, Huanqing Cheng, Shuaipeng Zhu, Meng Wang, Yanrui Zhang, Xiao Liu, Feng Lou, Shanbo Cao, Dingwei Y

Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 study

卡瑞利珠单抗联合吉西他滨和顺铂对肌层浸润性膀胱癌患者的新辅助治疗:一项多中心、单组、 2 期研究

Sujun Han, Zhigang Ji, Junhui Jiang, Xinrong Fan, Qi Ma, Linjun Hu, Wen Zhang, Hao Ping, Jiansong Wang, Wanhai Xu, Benkang Shi, Wei Wang, Haifeng Wang, Honglei Wang, Shouzhen Chen, Hailong Hu, Jianming Guo, Shen Zhang, Shuai Jiang, Quan Zhou, Nianzeng Xing

Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone

新型尿液生物标志物 lncRNA546 在提高 PSA 灰区前列腺癌诊断特异性方面的评估和多机构验证

Fei Liu, Xiaolei Shi, Fangming Wang, Sujun Han, Dong Chen, Xu Gao, Linhui Wang, Qiang Wei, Nianzeng Xing, Shancheng Ren

The circRAB3IP Mediated by eIF4A3 and LEF1 Contributes to Enzalutamide Resistance in Prostate Cancer by Targeting miR-133a-3p/miR-133b/SGK1 Pathway

eIF4A3 和 LEF1 介导的 circRAB3IP 通过靶向 miR-133a-3p/miR-133b/SGK1 通路导致前列腺癌对恩杂鲁胺产生耐药性

Dong Chen, Yaqin Wang, Feiya Yang, Adili Keranmu, Qingxin Zhao, Liyuan Wu, Sujun Han, Nianzeng Xing

Changes in Mitochondrial Toxicity in Peripheral Blood Mononuclear Cells During Four-Year Administration of Entecavir Monotherapy in Chinese Patients with Chronic Hepatitis B

恩替卡韦单药治疗四年期间,中国慢性乙型肝炎患者外周血单核细胞线粒体毒性的变化

Zhou, Li; Liu, Xiaoyu; Ren, Feng; Chen, Yu; Zheng, Sujun; Han, Yuanping; Zhao, Caiyan; Duan, Zhongping